排序方式: 共有11条查询结果,搜索用时 15 毫秒
1.
交联聚乙烯基吡咯烷酮的合成及其性能研究 总被引:2,自引:0,他引:2
以乙烯基吡咯烷酮(NVP)为单体,二乙烯基苯为交联剂,AIBN为引发剂,采用悬浮聚合法合成了性能稳定的交联聚乙烯基吡咯烷酮(PVPP),研究了聚合温度,引发剂用量,交联剂用量和反应气氛等因素对产率,溶胀性能和吸附性能的影响,并用红外光谱和扫描电镜等对产物的结构、性能和表面形貌进行了表征。 相似文献
2.
3.
Currently, high-performance liquid chromatographic (HPLC) methods are mainly used to measure antiretroviral plasma concentrations in HIV-infected patients. Although the utility of routine therapeutic drug monitoring (TDM) as an additional tool to optimize long-term antiretroviral therapy is unclear, if TDM is to be widely used, the availability of simple, cheap and reliable methods for the measurement of antiretroviral drug levels are needed, particularly in resource-limited settings. In this study, an immunochromatograhic (IC) strip test to detect the presence of nevirapine (NVP) in body fluids has been developed. Antiserum to NVP was first raised in rabbits by immunization against NVP chemically conjugated with bovine serum albumin, and subsequently validated by Western immunoblotting and competitive indirect ELISA. The partially purified anti-NVP antibodies were conjugated with colloidal gold particles. The conjugation of the colloidal gold and polyclonal antibodies was monitored by UV-vis spectroscopy, while transmission electron microscopy images were used to characterize the particle size and shape of the conjugates. The resulting colloidal gold conjugates were used for the production of an IC strip test to detect nevirapine in human plasma. Preliminary assessment suggests no-cross reactivity of the NVP polyclonal antibodies but assessment of plasma samples from HIV-infected patients receiving HAART needs to be conducted. This assay could potentially be used for drug monitoring as part of the clinical care of HIV infected patients. 相似文献
4.
5.
Yejing Weng Yanyan Qu Hao Jiang Qi Wu Lihua Zhang Huiming Yuan Yuan Zhou Xiaodan Zhang Yukui Zhang 《Analytica chimica acta》2014
Relative quantification of N-glycoproteomes shows great promise for the discovery of candidate biomarkers and therapeutic targets. The traditional protocol for quantitative analysis of glycoproteomes is usually off-line performed, and suffers from long sample preparation time, and the risk of sample loss or contamination due to manual manipulation. In this study, a novel integrated sample preparation platform for quantitative N-glycoproteome analysis was established, with combination of online N-glycopeptide capture by a HILIC column, sample buffer exchange by a N2-assisted HILIC–RPLC interface, deglycosylation by a hydrophilic PNGase F immobilized enzymatic reactor (hIMER) and solid dimethyl labeling on a C18 precolumn. To evaluate the performance of such a platform, two equal aliquots of immunoglobulin G (IgG) digests were sequentially pretreated, followed by MALDI-TOF MS analysis. The signal intensity ratio of heavy/light (H/L) labeled deglycosylated peptides with the equal aliquots was 1.00 (RSD = 6.2%, n = 3), much better than those obtained by the offline protocol, with H/L ratio as 0.76 (RSD = 11.6%, n = 3). Additionally, the total on-line sample preparation time was greatly shortened to 160 min, much faster than that of offline approach (24 h). Furthermore, such an integrated pretreatment platform was successfully applied to analyze the two kinds of hepatocarcinoma ascites syngeneic cell lines with high (Hca-F) and low (Hca-P) lymph node metastasis rates. For H/L labeled Hca-P lysates with the equal aliquots, 99.6% of log 2 ratios (H/L) of quantified glycopeptides ranged from −1 to 1, demonstrating high accuracy of the developed sample preparation strategy. By triplicated analysis of glycopeptides and non-glycopeptides of Hca-F and Hca-P lysates, 43 up-regulated and 30 down-regulated (Hca-F/P) N-glycosylation sites, and 11 significantly changed N-glycoproteins were successfully quantified, and most of them were related to tumorigenesis and tumor metastasis. All these results demonstrate the developed integrated N-glycoprotein pretreatment platform is of great power for the accurate, precise and high-throughput analysis of N-glycoproteomes. 相似文献
6.
NVP在全息聚合物分散液晶光栅中的反应动力学研究 总被引:1,自引:0,他引:1
为了提高全息聚合物分散液晶(简称HPDIC)光栅的衍射效率并得到良好的光栅表面形貌,在制备光栅的反应体系中添加了具有吡咯烷酮结构的单官能度小分子NVP,并进一步阐述了NVP对HPDLC光栅在反应动力学方面的影响.分析表明,NVP的添加显著增加了预聚单体的聚合速率,并且能使原本被困在聚合物网络当中的双键继续发生反应,从而大大提高了反应体系的双键转化率;另外,NVP的添加使得光栅的相分离更加彻底,在获得良好的表面形貌的同时也增大了光栅的折射率调制度,从而提高了HPDLC光栅的衍射效率.总之,在添加了NVP之后,体系的聚合速率和预聚单体的反应度都大大提高,从而使得光栅的表面形貌和衍射效率也得到较大的改善和提高,衍射效率提高到96.36%. 相似文献
7.
8.
9.
P(NIPA-co-NVP)温敏性凝胶微粒的药物释放与降解 总被引:1,自引:0,他引:1
本文采用N-异丙基丙烯酰胺(NIPA)与N-乙烯基吡咯烷酮(NVP),以N,N-亚甲基双丙烯酰胺(MBA)为交联剂,氧化-还原试剂引发,通过反相悬浮共聚制备了微粒状热缩温敏水凝胶;研究了共聚单体配比及交联剂用量对凝胶温敏性能和溶胀性能的影响,并利用其温敏性以水杨酸为模型药物进行了药物吸附-释放实验;利用红外光谱和显微技术对微凝胶的结构和形态进行了表征,并初步探讨了该凝胶降解的可能性。实验发现:NVP单体的加入使共聚凝胶的体积相变温度和平衡溶胀率都明显升高,药物吸附率增加,而溶胀-退溶胀的响应速度及水保留率降低,释药率降低;该凝胶在pH1,37℃条件下能够降解,降解率随单体中NVP含量的增加而增加,随交联剂用量的增加而降低。 相似文献
10.
The monomer 3‐ethyl‐1‐vinyl‐2‐pyrrolidone ( 3 ) and the homopolymer poly(3‐ethyl‐1‐vinyl‐2‐pyrrolidone) ( 5 ) have been synthesized. Polymer 5 is soluble in water and shows a critical temperature (Tc) of 27 °C. The presence of cyclodextrin causes a slight shift of the Tc. The lower critical solution temperature (LCST) could be varied between 27 and 40 °C by copolymerization with N‐vinyl‐2‐pyrrolidone. A linear correlation between the Tc and the copolymer composition is observed.